Temasek Holdings (private) Limited - Net Worth and Insider Trading
Temasek Holdings (private) Limited Net Worth
The estimated net worth of Temasek Holdings (private) Limited is at least $177 Million dollars as of 2025-01-15. Temasek Holdings (private) Limited is the 2201 Interest of corporation controlled by you of Ocumension Therapeutics and owns about 47,193,400 shares of Ocumension Therapeutics (HKSE:01477) stock worth over $177 Million. Details can be seen in Temasek Holdings (private) Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Temasek Holdings (private) Limited has not made any transactions after 2024-05-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Temasek Holdings (private) Limited
Temasek Holdings (private) Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Temasek Holdings (private) Limited owns 1 companies in total, including Ocumension Therapeutics (HKSE:01477) .
Insider Ownership Summary of Temasek Holdings (private) Limited
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01477 | Ocumension Therapeutics | 2024-05-10 | 2201 Interest of corporation controlled by you |
Temasek Holdings (private) Limited Latest Holdings Summary
Temasek Holdings (private) Limited currently owns a total of 1 stock. Temasek Holdings (private) Limited owns 47,193,400 shares of Ocumension Therapeutics (HKSE:01477) as of May 10, 2024, with a value of $177 Million.
Latest Holdings of Temasek Holdings (private) Limited
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:01477 | Ocumension Therapeutics | 2024-05-10 | 47,193,400 | 3.74 | 176,503,316 |
Holding Weightings of Temasek Holdings (private) Limited
Temasek Holdings (private) Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, Temasek Holdings (private) Limited has made a total of 3 transactions in Ocumension Therapeutics (HKSE:01477) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Ocumension Therapeutics is the sale of 1,500,000 shares on May 10, 2024, which brought Temasek Holdings (private) Limited around $11 Million.
Insider Trading History of Temasek Holdings (private) Limited
- 1
Temasek Holdings (private) Limited Trading Performance
Temasek Holdings (private) Limited Ownership Network
Ownership Network List of Temasek Holdings (private) Limited
Ownership Network Relation of Temasek Holdings (private) Limited
Temasek Holdings (private) Limited Owned Company Details
What does Ocumension Therapeutics do?
Who are the key executives at Ocumension Therapeutics?
Temasek Holdings (private) Limited is the 2201 Interest of corporation controlled by you of Ocumension Therapeutics. Other key executives at Ocumension Therapeutics include 2101 Beneficial owner Liu Ye , 2201 Interest of corporation controlled by you 6 Dimensions Capital GP, LLC , and 2101 Beneficial owner 6 Dimensions Capital, L.P. .
Ocumension Therapeutics (HKSE:01477) Insider Trades Summary
Over the past 18 months, Temasek Holdings (private) Limited made 2 insider transaction in Ocumension Therapeutics (HKSE:01477) with a net sale of 3,800,000. Other recent insider transactions involving Ocumension Therapeutics (HKSE:01477) include a net sale of 0 shares made by Liu Ye , a net purchase of 150,000 shares made by Boyu Capital Group Holdings Ltd , and a net sale of 427,000 shares made by The Capital Group Companies, Inc. .
In summary, during the past 3 months, insiders sold 0 shares of Ocumension Therapeutics (HKSE:01477) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,227,000 shares of Ocumension Therapeutics (HKSE:01477) were sold and 150,000 shares were bought by its insiders, resulting in a net sale of 4,077,000 shares.
Ocumension Therapeutics (HKSE:01477)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ocumension Therapeutics Insider Transactions
Temasek Holdings (private) Limited Mailing Address
Above is the net worth, insider trading, and ownership report for Temasek Holdings (private) Limited. Currently GuruFocus does not have mailing address information for Temasek Holdings (private) Limited.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
